000 | 00872 a2200253 4500 | ||
---|---|---|---|
005 | 20250513133703.0 | ||
264 | 0 | _c19980129 | |
008 | 199801s 0 0 eng d | ||
022 | _a0301-0147 | ||
024 | 7 |
_a10.1159/000217481 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLevine, M | |
245 | 0 | 0 |
_aTreatment of thrombotic disorders in cancer patients. _h[electronic resource] |
260 |
_bHaemostasis _c1997 |
||
300 |
_a38-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aHeparin _xadministration & dosage |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 |
_aThrombosis _xdrug therapy |
773 | 0 |
_tHaemostasis _gvol. 27 Suppl 1 _gp. 38-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000217481 _zAvailable from publisher's website |
999 |
_c9409051 _d9409051 |